Your session is about to expire
← Back to Search
Behavioural Intervention
Brain Stimulation for Memory Improvement in Healthy Adults
N/A
Waitlist Available
Led By Sven Vanneste, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age: 18-35 years Native English Speaker
Native English Speaker
Must not have
History of heart disease
History of epileptic insults
Timeline
Screening 3 weeks
Treatment Varies
Follow Up associate memory is assessed after a 10 minutes break following the study phase
Summary
This trial is investigating whether a brain stimulator can help people learn and remember better.
Who is the study for?
This trial is for healthy adults aged 18-35 who are native English speakers. It's not suitable for those with epilepsy, heart disease, severe psychiatric or untreated medical conditions, pregnant women, people with implanted devices, or a history of severe head injuries.
What is being tested?
The study tests if learning and memory recall can be improved using transcranial Direct Current Stimulation (tDCS) during a task that involves remembering faces and names. There are three approaches: active anodal tDCS, sham (fake) tDCS, and active cathodal tDCS.
What are the potential side effects?
Possible side effects of tDCS may include mild tingling on the scalp, itching under the electrode area, a slight headache or fatigue. These side effects are generally considered to be mild and temporary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 35 years old and speak English as my first language.
Select...
I am a native English speaker.
Select...
I am between 18 and 35 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of heart disease.
Select...
I have a history of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ associate memory is assessed after a 10 minutes break following the study phase
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~associate memory is assessed after a 10 minutes break following the study phase
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Associative Memory assessed by a Face Name Associate Memory experiment
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: active cathodal tDCSExperimental Treatment1 Intervention
active cathodal tDCS with Face Name associate Memory task
Group II: active anodal tDCSExperimental Treatment1 Intervention
active anodal tDCS with Face Name associate Memory task
Group III: Sham tDCSPlacebo Group1 Intervention
sham tDCS with Face Name associate Memory task
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
active anodal tDCS
2017
N/A
~90
Find a Location
Who is running the clinical trial?
The University of Texas at DallasLead Sponsor
64 Previous Clinical Trials
106,778 Total Patients Enrolled
7 Trials studying Healthy Adults
245 Patients Enrolled for Healthy Adults
Sven Vanneste, PhDPrincipal InvestigatorThe University of Texas at Dallas
6 Previous Clinical Trials
184 Total Patients Enrolled
1 Trials studying Healthy Adults
30 Patients Enrolled for Healthy Adults
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 35 years old and speak English as my first language.I have a history of heart disease.I am a native English speaker.I have a history of seizures.I am between 18 and 35 years old.
Research Study Groups:
This trial has the following groups:- Group 1: active anodal tDCS
- Group 2: Sham tDCS
- Group 3: active cathodal tDCS
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Healthy Adults Patient Testimony for trial: Trial Name: NCT03312920 — N/A
Share this study with friends
Copy Link
Messenger